Skip to main content

Enanta Pharmaceuticals Inc

ENTA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001177648

No open-market purchases or sales by Enanta Pharmaceuticals Inc insiders were filed in the last 90 days; 122 institutions reported holding it in 13F filings for Q2 2026, worth $397.2M in total; no superinvestor holds it.

Q4 2025 vs. Q3 2025

How the institutions holding Enanta Pharmaceuticals Inc changed between Q3 2025 and Q4 2025.

All holders in Q4 2025All holders in Q3 2025

13F holders of ENTA: Q3 2025 compared with Q4 2025
MeasureQ3 2025Of which not filed for Q4 2025Q4 2025Change
Holders1222132+12
Shares19.0M50.7K26.4M+7.45M (+39.3%)
Value$227.1M$607.1K$416.1M+$189.6M (+83.7%)

2 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (36)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q4 2025 but not at the end of Q3 2025.

Institutions new to ENTA in Q4 2025
InstitutionSharesValue% of portfolio
Deep Track Capital, LP1,956,867$30.9M0.70%
Hillsdale Investment Management Inc.422,300$6.66M0.18%
Spruce Street Capital LP389,687$6.15M2.03%
Citadel Advisors LLC93,158$1.47M0.00%
Opaleye Management Inc.75,000$1.18M0.16%
Panagora Asset Management Inc66,990$1.06M0.00%
Squarepoint Ops LLC65,966$1.04M0.00%
Diadema Partners LP65,138$1.03M0.61%
Wellington Management Group LLP63,219$997.0K0.00%
Arrowstreet Capital, Limited Partnership52,728$831.5K0.00%
ADAR1 Capital Management, LLC41,357$652.2K0.05%
EAM Investors, LLC40,952$645.8K0.07%
Prudential Financial Inc40,015$631.0K0.00%
Sio Capital Management, LLC40,000$630.8K0.10%
State of Wyoming32,887$518.6K0.06%
Franklin Resources Inc32,720$516.0K0.00%
Hudson Bay Capital Management LP30,000$473.1K0.00%
Headlands Technologies LLC22,596$356.3K0.03%
State of Wisconsin Investment Board18,608$293.4K0.00%
Persistent Asset Partners Ltd17,466$275.4K0.13%
Virtu Financial LLC13,967$220.0K0.01%
Jump Financial, LLC13,900$219.2K0.00%
Jain Global LLC12,543$197.8K0.00%
Kingsview Wealth Management, LLC10,653$168.0K0.00%
Fox Run Management, L.L.C.10,182$160.6K0.02%
Canada Pension Plan Investment Board8,900$140.4K0.00%
STRS Ohio3,200$50.5K0.00%
Pinnacle Wealth Planning Services, Inc.2,529$39.9K0.00%
Seven Fleet Capital Management LP2,270$35.8K0.02%
Meeder Asset Management Inc2,025$31.9K0.00%
Rockefeller Capital Management L.P.514$8.11K0.00%
Daiwa Securities Group Inc.96$2.00K0.00%
Torren Management, LLC120$1.89K0.00%
Los Angeles Capital Management LLC103$1.12K0.00%
Parallel Advisors, LLC51$8040.00%
MAI Capital Management7$1110.00%

Sold out (24)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2025 and filed for Q4 2025 without it.

Not filed for Q4 2025 yet (2)

Institutions that held Enanta Pharmaceuticals Inc at the end of Q3 2025 and haven't filed a 13F for Q4 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ENTA in Q3 2025 that haven't filed for Q4 2025
InstitutionShares, Q3 2025Value, Q3 2025
Cubist Systematic Strategies, LLC49,983$598.3K
Point72 (DIFC) Ltd739$8.85K